These aren’t important questions. Shares traded post liquidation because the board had resigned after the failure of the SISP. FINRA stepped in after it was notified of the outcome by the Monitor per its 10th Report.
This was absolutely addressed by the Company, the Monitor and judges, who each said in separate documents in very plain English the reality related to the shares. Nothing since has refuted any of that.
Shares continue to trade up until everything is finalized. That’s why there is a Q attached to the ticker symbol. That’s common and happens all the time. As far as addressing the shares it’s right in the docs. It’s shown clearly in the court docs and monitors reports. They show that creditors were not even close to paid and shareholders are last in that list. They show that nobody wanted to take on BioAmber as a going concern and BioAmber was liquidated in the end. All of that shows the shares are toast. They also state that all assets were sold save and except a few items and that there is NO value for equity investors meaning shareholders got nada. It’s all right there if one chooses to read the official documents instead of listening to fabricated lies of a liquidated company somehow paying its shareholders a windfall.
Market Data 
Markets 
AI
